Quanterix Corp (QTRX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Quanterix Corp (QTRX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7861
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Quanterix Corp (Quanterix) is a life sciences company that develops and markets ultra-sensitive digital immunoassay platform that improves precision health for life sciences research and diagnostics. The company develops platform based on its proprietary digital single molecule array, Simoa detection technology that allows the detection of proteins and nucleic acids in biological samples. Quanterix’s kits include components required to run tests, such as capture and detector reagents, beads, enzyme reagents and enzyme substrates. Its consumables include Simoa disks, cuvettes and disposable tips. Its technology is used for research applications in various therapeutic areas, including neurology, cardiology, oncology, inflammation and infectious diseases. The company’s Simoa technology serves life science research, diagnostics and precision health screening markets. It also provides contract research services. Quanterix is headquartered in Lexington, Massachusetts, the US.

Quanterix Corp (QTRX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Quanterix Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Quanterix Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Quanterix Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Quanterix Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Quanterix Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Quanterix Corp, Medical Equipment, Deal Details 12
Venture Financing 12
Aushon BioSystems Raises Additional USD3 Million in Venture Financing 12
Aushon BioSystems Raises USD3.6 Million in Financing Round 13
Quanterix Raises USD46 Million in Series D Financing 14
Aushon BioSystems Raises USD8 million in Venture Financing 16
Quanterix Raises US$1 Million In Venture Financing 17
Quanterix Raises US$19 Million In Series C Financing 18
Aushon BioSystems Raises US$5.5 Million In Venture Financing 20
Quanterix Raises US$2 Million In Venture Financing 21
Quanterix Secures Investment In Venture Financing 22
Partnerships 23
Quanterix Enters into Licensing Agreement with Banyan Biomarkers 23
bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 24
Quanterix Enters into Agreement with DestiNA Genomics 25
ADx NeuroSciences Enters into Agreement with Quanterix 26
Quanterix Enters into Agreement with Frontage Labs 27
Quanterix, Beth Israel Deaconess And Forsyth Institute Enter Into Partnership To Develop Tuberculosis Test 28
Aushon BiosyStems Enters Into Distribution Agreement With Fisher Scientific 30
Equity Offering 31
Quanterix Raises USD73.7 Million in IPO 31
Quanterix Raises USD8.5 Million in Private Placement 33
Quanterix Invests in Immunarray 34
Acquisition 35
Lepu Medical Plans to Acquire 5.35% Stake in Quanterix for USD11 Million 35
Quanterix Corp – Key Competitors 36
Quanterix Corp – Key Employees 37
Quanterix Corp – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 39
Strategy And Business Planning 39
Jun 15, 2017: Frontage Laboratories Announces Partnership With Quanterix And Validation Of Simoa Hd-1 Analyzer And Software To Support Biomarker Analysis 39
Financial Announcements 40
Aug 08, 2018: Quanterix releases operating results for second quarter 2018 40
May 09, 2018: Quanterix Releases Operating Results for First Quarter 2018 41
Mar 14, 2018: Quanterix Releases Operating Results for Fourth Quarter and Fiscal Year 2017 42
Jan 10, 2018: Quanterix: Results of Operations and Financial Condition 43
Corporate Communications 44
Aug 03, 2017: Quanterix Raises $8.5 Million In Private Financing Led By T. Rowe Price Associates; Also Appoints Dr. Marijn Dekkers To Company’S Board Of Directors And Several Key Executives To Its Leadership Team 44
Product News 45
Oct 09, 2018: Quanterix Simoa Technology powers record number of presentations and poster sessions at ECTRIMS 2018 45
Jul 23, 2018: Quanterix’ Ultra-Sensitive Technology Creates Breakthroughs in Brain Health of Military and Veterans 46
Oct 17, 2017: Dr. David Walt of Wyss Institute to Speak at Powering Precision Health 2017 47
Aug 15, 2017: Quanterix To Launch High-Sensitivity Benchtop Instrument And Assays For Multiplex Biomarker Detection 48
Jul 18, 2017: Quanterix, Partners Develop PCR-free miRNA Detection Method for Liver Toxicity Testing 49
Jul 06, 2017: Single Molecule Microrna Technology Proves Useful for Liver Toxicity Detection 50
May 17, 2017: Quanterix Launches The First Comprehensive Multiplex Panel To Study Traumatic Brain Injury Severity 51
Apr 14, 2017: Quanterix To Present Webinar On Protein Quantification And Identification In Personalized Medicine 52
Jan 05, 2017: Quanterix to Present at The 35th Annual J.P. Morgan Healthcare Conference 53
Other Significant Developments 54
Apr 27, 2018: Quanterix Marks Leadership in Accelerating Neurology Research with 100-Publication Milestone 54
Jul 18, 2017: Quanterix Boosts Investments in its Accelerator Lab to Support Rapid Growth of Simoa Technology 55
May 09, 2017: Smithers Avanza Adds Quanterix’ Simoa Technology To Bioanalytical Laboratory 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57

List of Tables
Quanterix Corp, Medical Equipment, Key Facts, 2017 2
Quanterix Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Quanterix Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Quanterix Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Quanterix Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Quanterix Corp, Deals By Market, 2012 to YTD 2018 9
Quanterix Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Aushon BioSystems Raises Additional USD3 Million in Venture Financing 12
Aushon BioSystems Raises USD3.6 Million in Financing Round 13
Quanterix Raises USD46 Million in Series D Financing 14
Aushon BioSystems Raises USD8 million in Venture Financing 16
Quanterix Raises US$1 Million In Venture Financing 17
Quanterix Raises US$19 Million In Series C Financing 18
Aushon BioSystems Raises US$5.5 Million In Venture Financing 20
Quanterix Raises US$2 Million In Venture Financing 21
Quanterix Secures Investment In Venture Financing 22
Quanterix Enters into Licensing Agreement with Banyan Biomarkers 23
bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 24
Quanterix Enters into Agreement with DestiNA Genomics 25
ADx NeuroSciences Enters into Agreement with Quanterix 26
Quanterix Enters into Agreement with Frontage Labs 27
Quanterix, Beth Israel Deaconess And Forsyth Institute Enter Into Partnership To Develop Tuberculosis Test 28
Aushon BiosyStems Enters Into Distribution Agreement With Fisher Scientific 30
Quanterix Raises USD73.7 Million in IPO 31
Quanterix Raises USD8.5 Million in Private Placement 33
Quanterix Invests in Immunarray 34
Lepu Medical Plans to Acquire 5.35% Stake in Quanterix for USD11 Million 35
Quanterix Corp, Key Competitors 36
Quanterix Corp, Key Employees 37
Quanterix Corp, Subsidiaries 38

List of Figures
Quanterix Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Quanterix Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Quanterix Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Quanterix Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Quanterix Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Quanterix Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Quanterix Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Quanterix Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Quanterix Corp (QTRX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Etablissementen Franz Colruyt NV (COLR):企業の財務・戦略的SWOT分析
    Etablissementen Franz Colruyt NV (COLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • iMedX Inc:医療機器:M&Aディール及び事業提携情報
    Summary iMedX Inc (iMedX) is a provider of medical document management and health information solutions. The company offers transcription services and coding services. It provides iMedX Express web based platforms and iMedX Mobile with DocAssist applications. iMedX’s transcription services comprise …
  • Citizens Financial Corp.:企業の戦略・SWOT・財務情報
    Citizens Financial Corp. - Strategy, SWOT and Corporate Finance Report Summary Citizens Financial Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Alkermes Plc (ALKS):企業の財務・戦略的SWOT分析
    Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Novatek (NVTK):石油・ガス:M&Aディール及び事業提携情報
    Summary Novatek (Novatek) is an independent oil and gas company. The company explores, produces, processes, and markets natural gas and liquid hydrocarbons. Its licensed producing fields include, Yurkharovskoye, East-Tarkosalinskoye, Khancheyskoye, Olimpiyskiy, Yumantilskiy, Samburgskiy, North-Ureng …
  • University of California Berkeley:製薬・医療:M&Aディール及び事業提携情報
    Summary University of California Berkeley (UC Berkeley), a subsidiary of University of California is an educational university that offers educational programs and research services. The university’s academic programs comprise law and economics program, legal studies; lesbian, gay, bisexual, and tra …
  • Epicor Software Corp:企業の戦略的SWOT分析
    Epicor Software Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • WESCO International, Inc.:企業の戦略・SWOT・財務情報
    WESCO International, Inc. - Strategy, SWOT and Corporate Finance Report Summary WESCO International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Yamana Gold Inc.:企業の戦略・SWOT・財務分析
    Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • China Investment Corp:企業のM&A・事業提携・投資動向
    China Investment Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Investment Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Gardiner & Theobald LLP:企業の戦略的SWOT分析
    Gardiner & Theobald LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • AliveCor Inc:医療機器:M&Aディール及び事業提携情報
    Summary AliveCor Inc (AliveCor) is a heart rate measuring technology provider. The company offers kardia mobile and kardia application. It provides medical-grade EKG in just thirty seconds. AliveCor’s kardia offers easy to use, affordable, portable and trusted. The company track data over time and m …
  • Hyundai Motor Co (005380):企業の財務・戦略的SWOT分析
    Hyundai Motor Co (005380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lipocine Inc (LPCN):製薬・医療:M&Aディール及び事業提携情報
    Summary Lipocine Inc (Lipocine) is a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testosterone produ …
  • Hot Topic, Inc.:企業の戦略・SWOT・財務情報
    Hot Topic, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hot Topic, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Madico Inc:企業の戦略的SWOT分析
    Madico Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Acceleron Pharma Inc (XLRN):企業の財務・戦略的SWOT分析
    Acceleron Pharma Inc (XLRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • PerkinElmer Inc (PKI):企業の財務・戦略的SWOT分析
    PerkinElmer Inc (PKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SAES Getters S.p.A. (SG):企業の財務・戦略的SWOT分析
    SAES Getters S.p.A. (SG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • KemPharm Inc (KMPH):企業の財務・戦略的SWOT分析
    Summary KemPharm Inc (KemPharm) is a clinical-stage specialty pharmaceutical company that offers discovery and development of proprietary new molecular entity prodrugs. The company’s product pipeline includes KP415, methylphenidate drug for ADHD; KP201/IR, KP511/ER, KP606/IR and KP746 drugs for the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆